Skip to content

A study of treatment of general malaise with conditioned medium

A study of treatment of general malaise with human-derived mesenchymal stem cell conditioned medium

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT1051220089
Enrollment
20
Registered
2022-09-14
Start date
2022-08-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fatigue Syndrome

Interventions

None listed

Sponsors

Inami Norihito
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: "1. Patients who did not have a satisfactory therapeutic effect with standard treatment by a general physician 2. Patients who do not wish to be treated with the drugs used in standard treatment due to concerns about side effects, etc., and those who have been judged by the doctor that chronic pain treatment with conditioned medium is optimal. Target patients who meet the following criteria. 1. 18 years old and over 2. Have normal consent ability 3. Patients who can obtain their free will consent in writing 4. Patients whose doctor have recognized the need for treatment "

Exclusion criteria

Exclusion criteria: Patient who meet any of the following conditions are excluded 1. Have a history of or suspected of dementia 2. Users of narcotics or stimulants 3. Pregnant, breastfeeding 4. Judged unsuitable by the doctor

Design outcomes

Primary

MeasureTime frame
subjective symptoms, Simple Fatigue Scale.

Secondary

MeasureTime frame
High-sensitivity CRP, galectin-3, adiponectin, total antioxidant capacity . Grip strength, body composition (weight, muscle mass).

Contacts

Public ContactYoshiki Murata

Seihoku Clinic

mochizuki@shhc.jp+81-78-998-1101

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026